Francais
info@saveyourskin.ca

Webinar

Understanding Cutaneous Reactions in Advanced Cancer Treatments

 

Join Dr. Joël Claveau as he delves into the complexities of targeted therapy and immunotherapy, innovative cancer treatments known for their efficacy but also for potential side effects. Gain insights into the unique dermatological reactions associated with these medications, including their impact on skin, hair, nails, and eyes. Understand the nuances and differences in side effects compared to traditional chemotherapy drugs, empowering patients and healthcare professionals with essential knowledge for informed decision-making and proactive care.

 

 

 

Speaker:

Dr. Joël Claveau
Dermatologist, Ville de Québec, QC

Dr. Joël Claveau is a dermatologist, specialized in the diagnosis and treatment of Melanoma and Skin Cancers, and an Associate Professor with the Department of Medicine at Laval University where he completed his Medical Study and Internal Medicine training. He did his residency in Dermatology at McGill University and subsequently worked at the Melanoma Clinic at the Royal Victoria Hospital in Montreal, Quebec. He is a diplomat of the American Board of Dermatology and is a member of a number of Medical Societies including the American Academy of Dermatology and the International Dermoscopy Society.

He has received awards including Honorary Member of La Société Française de Dermatologie, the Dermatologist’s Volunteer Award of the Canadian Dermatology Association (CDA) for his work on the prevention of skin cancers and the CDA Symposium of the year on two occasions (Dermoscopy). Since 1996, he has been the Director of the Melanoma and Skin Cancer Clinic at Le Centre Hospitalier Universitaire, Hôtel-Dieu de Québec, and worked in Public Health for the province of Québec, especially on the new Tanning Bed Legislation. He participated to the publication of papers in peer-reviewed journals including work on melanoma, skin cancers and sunscreens. He is actively involved in various Continuing Medical Education events and investigator in many clinical trials on advanced and metastatic melanoma.

When:

February 28th at 8 PM ET | 5PM ET

Register: 

https://us06web.zoom.us/webinar/register/WN_xRUxwey-Rq2AlFt8tSrkgQ

 

Read more

Understanding the Drug Approval Process: From Clinical Trials to Public Reimbursement

This webinar will discuss the drug approval process starting from clinical trials to public reimbursement.

Our expert speakers will explain how clinical trials are designed, how to find and access clinical trials in Canada, and how to determine if they are right for you.

Attendees will learn how drugs get approved in Canada and who the stakeholders involved are, following the process from clinical trials and efficacy reviews to patient submissions and Health Canada approvals, and finally, provincial reimbursement.

Moderated by Kathy Barnard, Founder/President of Save Your Skin Foundation, Stage IV Melanoma Survivor

START TIME:
8PM EST | 5PM PST | 6PM MST | 9:30PM NST | 9PM AST

Click here for more information

Read more

Understanding the Drug Approval Process: From Clinical Trials to Public Reimbursement

Thank you so much to all who attended our webinar!

If you weren’t able to join us live, you can watch the recording of the symposium on our Youtube channel.

Date: 
April 19, 2023

Start Time:
Starts: 8pm EST | 5pm PST | 6pm MST | 9:30pm NST | 9pm AST

This webinar will discuss the drug approval process starting from clinical trials to public reimbursement.

Our expert speakers will explain how clinical trials are designed, how to find and access clinical trials in Canada, and how to determine if they are right for you.

Attendees will learn how drugs get approved in Canada and who the stakeholders involved are, following the process from clinical trials and efficacy reviews to patient submissions and Health Canada approvals, and finally, provincial reimbursement.

Moderated by Kathy Barnard, Founder/President of Save Your Skin Foundation, Stage IV Melanoma Survivor

Our Key Presenters:

  • Dawn Richards, PhD, Director of Patient and Public Engagement at Clinical Trials Ontario, Founder of Five02Labs
  • Louise Binder, Lawyer, Senior Health Policy Expert at Save Your Skin Foundation

ADDITIONAL INFORMATION

Kathleen Barnard is Founder and President of Save Your Skin Foundation (SYSF), a national not-for-profit group dedicated to the prevention of non-melanoma skin cancers, melanoma, and ocular melanoma. In 2003, Kathy was diagnosed with stage 4 malignant melanoma. By the establishment of SYSF in 2006, her cancer had spread to her vital organs and her treatment options were limited. Fortunately, one of her sons discovered an immunotherapy trial treatment taking place in Alberta, Canada; this trial would save Kathy’s life. While her cancer treatments have finished, the battle with melanoma is not over for Barnard. Kathy prioritizes patient care and support. Kathy was a key player in federal tanning bed legislation for Canada’s Youth, and is the recipient of the British Columbia Community Achievement Award for her leadership in addressing and raising awareness around skin cancer issues. Additionally, Kathy is on the Conference Board of Canada advisory committee for Value of Oncology Innovation in Canada.

Louise Binder is a lawyer and health advocate who has been involved in informing the development of health policy and systemic treatment access practices from a patient perspective for more than 20 years. She started her work in this area in the HIV community in the early 1990s after her own diagnosis and before effective treatments were available for HIV.

She co-founded the Canadian Treatment Action Council (CTAC) in 1996, which successfully ensured access to treatments and quality care for people living with HIV by working with the federal and provincial governments and other relevant stakeholders to enhance drug review and approval systems, pricing policies and access to liver transplants for this community. She wrote a paper on universal drug coverage a decade ago while chair of CTAC.

She had a special interest in women’s issues, chairing the Ontario women’s organization Voice of Positive Women for more than a decade, and has been involved in these issues internationally as well. Two years ago, Louise began similar work in the cancer area and is presently a Health Policy Consultant with Save Your Skin Foundation. She has been recognized by many organizations for her work, including receiving an Honorary Doctorate of Laws from her alma mater, Queen’s Law School; the Order of Ontario from the Province of Ontario; and two Queen Elizabeth II medals.

Dawn Richards, PhD, is the founder of Five02 Labs Inc., and Director of Patient and Public Engagement at Clinical Trials Ontario. With a PhD (Analytical Chemistry) from the University of Alberta, and experience in a variety of roles during the past 20 years, it is her diagnosis with rheumatoid arthritis in 2006 that started her journey to combine her passion for science with making the most of her diagnosis. In her role at CTO, Dawn is charged with executing on CTO’s strategic pillar of patient and public engagement.

Read more

Ocular Melanoma Patient & Caregiver Symposium

Happening virtually over two days, April 15 & 16, 2023, the first Canadian OM Patient & Caregiver Symposium will include presentations by Canada’s leading experts in Ocular Oncology and patients living with Primary and Metastatic Ocular Melanoma.
Stay tuned for more details and registration!
Read more

Webinar – Post-CMC 2023 Update from Dr. Smylie

Date/Time:  March 1 – 5pm-6:30 pm PT / 8pm-9:30 pm ET

Presented by Dr. Michael Smylie, Cross Cancer Institute, Edmonton, this webinar will review breaking news, key takeaways, clinical data and other updates presented at the Canadian Melanoma Conference (CMC) taking place in Banff, Alberta, from February 23-25, 2023. Dr. Smylie will present on key clinical trial data from 2022 in the management of melanoma, the latest strategies in melanoma as they pertain to medical oncology, pathology, radiation and surgery, and implementation approaches that maximize patient standard of care in melanoma. Dr. Michael Smylie is a medical oncologist at the Cross Cancer Institute, and a professor at the Department of Oncology at the University of Alberta in Edmonton

View Webinar Recording (English) Here

Presenters:

  • Kathy Barnard, President, SYSF, melanoma stage 4 survivor
  • Dr. Michael Smylie, Medical Oncologist, Cross Cancer Institute, Professor, Department of Oncology, University of Alberta, Edmonton

More on CMC

This conference brings together medical oncologists, surgeons, dermatologists, radiotherapists, pathologists, molecular biologists, immunologists, and other allied health professionals interested in the treatment of melanoma worldwide.

  1. Describe key clinical trial data from 2022 in the management of melanoma and understand the impact on Canadian practices.
  2. Understand the latest strategies in melanoma as they pertain to medical oncology, pathology, radiation, and surgery.
  3. Implement approaches that maximize patient standard of care in melanoma.
Read more

Webinar – Living with Cancer: Survivorship & Mental Wellness

Date/Time:  November 23, 2022 – 5pm-6:30 pm PT / 8pm-9:30 pm ET

This webinar will focus on the experience of cancer survivors and the importance of mental wellness from the perspective of four women with unique backgrounds and experiences in the cancer space. Shannon Gaudette, a melanoma stage 4 survivor, will talk about her physical and emotional wellbeing throughout her cancer experience. She will be followed by Antonella Scali, Executive Director of the Canadian Psoriasis Network and the daughter of a cancer survivor, who will talk about the results of a survey completed by All.Can Canada and implications for mental health and the need for psychosocial supports. Then, Kathy Barnard, president of the Save Your Skin Foundation and a melanoma stage 4 survivor, will talk about her experience as a long-time survivor. Finally, Lyanne Westie, SYSF wellness support consultant, will present on the importance of mental wellness in all aspects of life. These short presentations will be followed by a discussion between the four presenters, with time for questions from webinar attendees.

Watch the recording here

Presenters:

  • Kathy Barnard, President, SYSF, melanoma stage 4 survivor
  • Antonella Scali, MSW RSW, Executive Director, Canadian Psoriasis Network
  • Shannon Gaudette, melanoma stage 4 survivor
  • Lyanne Westie, SYSF wellness support consultant
Read more

Upcoming Webinar: Prognostic Testing and What It Means to Ocular Melanoma Patients

Join us for a free webinar on Wednesday, September 14 at 5pm PST | 8pm EST.

In this webinar, Katherina Alsina, PhD, Castle BioSciences, Dr. Ezekiel Weis, Provincial Medical Lead, Alberta Ocular Brachytherapy Program, and Dr. Marcus Butler, Medical Oncologist, Princess Margaret Cancer Centre, will help patients understand prognostic testing when diagnosed with Ocular Melanoma. They will also discuss options for HCPs for prognostic testing, what it can mean to patients and how it can affect treatment decisions. The presentations will be followed by a live Q&A session.
Click here to register
Read more

WEBINAR: Latest news on melanoma/skin cancer/ocular melanoma from ASCO 2022

(le français suit)

Don’t miss our webinar with Dr. Marcus Butler, the Medical Oncology Disease Site Lead for Melanoma/Skin Oncology at Princess Margaret Cancer Centre and Assistant Professor of Medicine at the University of Toronto. He is also the Clinical Director for the Immune Monitoring Team at the Princess Margaret where he focuses on the immunologic impact of anti-cancer immunotherapies.

This webinar reviews late breaking news, key takeaways, clinical data and other updates presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place in Chicago, Illinois, in June 2022.

Dr. Butler shares his key insights into what the landscape of melanoma, non-melanoma skin cancers, and ocular melanoma treatment looks like for the near future in Canada.

Click HERE to view the recording

 

WEBINAIRE : Mise à jour sur le mélanome/cancer de la peau/mélanome oculaire de l’ASCO 2022

Regardez l’enregistrement du webinaire avec le Dr Marcus Butler, responsable du site d’oncologie médicale pour le mélanome et l’oncologie de la peau au Princess Margaret Cancer Centre et professeur adjoint de médecine à l’Université de Toronto. Il est également le directeur clinique de l’équipe de surveillance immunitaire du Princess Margaret, où il se concentre sur l’impact immunologique des immunothérapies anticancéreuses.

Ce webinaire a passé en revue les dernières nouvelles, les points essentiels, les données cliniques et d’autres mises à jour présentées lors de l’assemblée annuelle de l’American Society of Clinical Oncology (ASCO) qui a eu lieu à Chicago, en Illinois, en juin 2022.

Le Dr Butler a partagé ses idées clés sur ce à quoi ressemble le paysage du traitement du mélanome, des cancers de la peau autres que le mélanome et du mélanome oculaire dans un avenir proche au Canada.

Cliquez ici pour le webinaire

Read more

Webinar: Diagnosed with Skin Cancer? Here’s What To Do Next

View the recording of our webinar ~ February 24, 2022

An Hour with Kathy Barnard

In this webinar, Kathy Barnard, founder of SYSF and melanoma survivor, shares her experience navigating and advocating through the Canadian health care system, which is complicated and can be confusing to many. She helps patients and caregivers understand how to get from diagnosis to surgical and/or systemic treatment of melanoma or non-melanoma skin cancer (NMSC) such as metastatic basal cell carcinoma (BCC), squamous cell carcinoma (SCC) or merkel cell carcinoma (MCC).

Click HERE to view the recording!

And click HERE to download/print a list of Questions you can ask your Doctor

Read more

Announcing the GetSkinHelp mobile app!

We want you to #StopWaiting and get your skin checked as part of #DigitalHealthWeek!

SYSF is proud to be partnering with Skinopathy for the launch of their mobile app: GetSkinHelp

The GetSkinHelp mobile app allows individuals to access the SkinAI™ technology – an embedded artificial intelligence that allows people to quickly analyze for a selection of skin diseases, including skin cancers – and schedule video appointments with a licensed Canadian doctor who can help determine next steps.

From there, the doctor might suggest an in-person appointment or simply write a prescription, which will be sent to the patient’s home or pharmacy. What is most important is that the app gets a person in front of a doctor faster than traditional means.

Watch this video to learn more:

 

Download the new free #GetSkinHelp app and have your skin concerns analyzed by their SkinAI™ technology. You can then schedule an appointment with a skin doctor and have them check it out virtually. And best of all, it is all covered by provincial health plans!

#StopWaiting and download the app now to get the medical attention YOU need:

Download the app for Apple  |  Download the app for Android

 

See a licensed doctor and heal your skin. All online. On any device.
And covered by Canadian health cards.

In the summer of 2020, Dr. Colin Hong and entrepreneur Keith Loo noticed that the medical delays caused by the pandemic had resulted in greater occurrences of late stage skin cancers being diagnosed. A few months later they created Skinopathy, a medtech company with one simple goal: find answers on how they can help solve this growing public concern.

Save Your Skin Foundation is proud to support the launch of GetSkinHelp – a new service covered by Canadian health cards that allows people to get prompt and virtual medical attention when it comes to skin diseases and skin cancers. Click here to read the press release

At Save Your Skin Foundation, we are an organization dedicated to reducing skin cancers in Canada and providing compassionate support to those living with skin cancer. And we are always on the lookout for ways that can help with that mandate, but we also acknowledge we are not the experts on advanced technology.

As part of Digital Health Week and the #StopWaiting and Get Skin Help campaign, with the folks at Skinopathy, we hosted this roundtable that will help us understand how healthcare is changing due to new technologies, and what needs to happen to keep patients safe. 

The Future of Healthcare – Just Because We Can, Doesn’t Always Mean We Should

Healthcare and technology luminaries discuss how modern technology and social trends are changing healthcare, but are they all good things and what can be done to safeguard patients?

Moderated by Dr. Jonathan Reichental, with Guests – Ashley Casovan, Pirth Singh, and Keith Loo. Click here to view the Roundtable Discussion:

 

#StopWaiting and GetSkinHelp

Download the app for Apple  |  Download the app for Android

***Moderator***

Dr. Jonathan Reichental

Dr. Reichental is the founder of the advisory, investment, and education firm, Human Future. He is also a multiple-award-winning technology and business leader whose career has spanned both the private and public sectors. Most notably, he served as the chief information officer for the City of Palo Alto in California and in 2017 was named one of the top 100 CIOs in the World.

***Guests***

Ashley Casovan

Ashley has been at the forefront of building tools and policy interventions to support the responsible use and adoption of innovative technologies, both with her work at the Government of Canada, and now as the Executive Director of the Responsible AI Institute. She was also named as one of the top 100 most influential Young People in Government by Apolitical in 2018.

Pirth Singh

Pirth is a government maverick and trailblazer who has helped the government of Canada embrace open source technologies. He is now the Assistant Director General for the Industry Canada Innovation, Science and Economic Development team where he is leading the work on the development and implementation of digital credentials.

Keith Loo

Keith is the CEO and Co-Founder of Skinopathy, a Canadian medical technology startup that is revolutionizing the patient circle-of-care. He is heavily involved in the Canadian tech start-up community, consults out of several incubators and accelerators in the Greater Toronto Area, and is an entrepreneurship instructor at the Schulich School of Business.

 

Read more